Regeneration of Partial Anterior Cruciate Ligament Tears Using the Technique of Biologic Augmentation with Bone Marrow Concentrate and Platelet-Rich Plasma Under Arthroscopic Visualization A Prospective Study at 2-Year Follow-Up
Main Article Content
Keywords
ACL primary repair, ACL biologic repair, ACL tear, biologic augmentation, BMAC, knee arthroscopy, platelet-rich plasma
Abstract
To present clinical outcomes in a preliminary patient cohort using a biologic augmentation technique consisting of intra-ligamentous and intra-articular infiltration of bone marrow aspirate concentrate (BMAC) and platelet-rich plasma (PRP) under arthroscopic visualization for treatment of isolated and acute partial anterior cruciate ligament (ACL) tears. Athletes with an acute symptomatic partial ACL injury with clinical examination findings of increased anterior tibial translation without rotational instability were treated with the biologic augmentation technique. Patients were followed for 2 years postoperatively. The Lysholm Knee Questionnaire, IKDC Objective score, physical examination findings, MRI, and the KT-1000 arthrometer were used to assess clinical outcomes. Five patients were included in the analysis with a median age of 22. All patients were determined to have a healed ACL on MRI 8 months postoperatively. The median Lysholm Score at the final follow-up of 99 was significantly increased from the median pre-operative score (p = 0.042). In addition, the objective IKDC score improved in all patients postoperatively, and no clinical examination findings of knee instability were identified at the final follow-up. The median side-to-side difference in KT-1000 arthrometer testing was 3 mm pre-operatively and 0 mm at the last follow-up (p = 0.038). The treatment of appropriately indicated partial ACL injuries in this study has demonstrated that restoration of ligamentous structure and function may be achieved by a biologic augmentation technique using intra-ligamentous and intra-articular infiltration of BMAC and PRP. This technique is performed with minimal technical difficulty, leading to excellent 2-year clinical outcomes in this preliminary series of patients.
References
2. Sonnery-Cottet B, Colombet P. Partial tears of the anterior cruciate ligament. Orthopaedics & traumatology, surgery & research : OTSR. 2016.
3. Woo SL, Vogrin TM, Abramowitch SD. Healing and repair of ligament injuries in the knee. The Journal of the American Academy of Orthopaedic Surgeons. 2000;8(6):364-72.
4. Proffen BL, Sieker JT, Murray MM. Bio-Enhanced Repair of the Anterior Cruciate Ligament. Arthroscopy.31(5):990-7.
5. Lohmander LS, Englund PM, Dahl LL, Roos EM. The long-term consequence of anterior cruciate ligament and meniscus injuries: osteoarthritis. The American journal of sports medicine. 2007;35(10):1756-69.
6. Dallo I, Chahla J, Mitchell JJ, Pascual-Garrido C, Feagin JA, LaPrade RF. Biologic Approaches for the Treatment of Partial Tears of the Anterior Cruciate Ligament: A Current Concepts Review. Orthopaedic journal of sports medicine. 2017;5(1):2325967116681724.
7. Graeme P. Whyte ID, Katarzyna Herman, andAlberto Gobbi. Future Trends in Ligament Surgery. The Role of Biology. ISAKOS Book Springer2019.
8. Dallo Ignacio VK, Eleonora Irlandini. State of The Art for Injections in Orthopaedics. ISAKOS Newsletter2020.
9. Dallo I, Frank RM, Bradsell H, Piuzzi NS, Gobbi A. Overview of Orthobiologics and Joint Function. In: Gobbi A, Lane JG, Longo UG, Dallo I, editors. Joint Function Preservation: A Focus on the Osteochondral Unit. Cham: Springer International Publishing; 2022. p. 21-31.
10. Gobbi A, Whyte GP. Long-term Outcomes of Primary Repair of the Anterior Cruciate Ligament Combined With Biologic Healing Augmentation to Treat Incomplete Tears. The American journal of sports medicine. 2018;46(14):3368-77.
11. Panisset JC, Duraffour H, Vasconcelos W, Colombet P, Javois C, Potel JF, et al. [Clinical, radiological and arthroscopic analysis of the ACL tear. A prospective study of 418 cases]. Revue de chirurgie orthopedique et reparatrice de l'appareil moteur. 2008;94(8 Suppl):362-8.
12. Noyes FR, Mooar LA, Moorman CT, 3rd, McGinniss GH. Partial tears of the anterior cruciate ligament. Progression to complete ligament deficiency. The Journal of bone and joint surgery British volume. 1989;71(5):825-33.
13. DeFranco MJ, Bach BR, Jr. A comprehensive review of partial anterior cruciate ligament tears. The Journal of bone and joint surgery American volume. 2009;91(1):198-208.
14. Gobbi A, Karnatzikos G, Sankineani SR, Petrera M. Biological Augmentation of ACL Refixation in Partial Lesions in a Group of Athletes: Results at the 5-Year Follow-up. Techniques in Orthopaedics. 2013;28(2):180-4.
15. Noyes FR, DeLucas JL, Torvik PJ. Biomechanics of anterior cruciate ligament failure: an analysis of strain-rate sensitivity and mechanisms of failure in primates. The Journal of bone and joint surgery American volume. 1974;56(2):236-53.
16. Costa-Paz M, Ayerza MA, Tanoira I, Astoul J, Muscolo DL. Spontaneous healing in complete ACL ruptures: a clinical and MRI study. Clinical orthopaedics and related research. 2012;470(4):979-85.
17. Zicaro JP, Garcia-Mansilla I, Zuain A, Yacuzzi C, Costa-Paz M. Has platelet-rich plasma any role in partial tears of the anterior cruciate ligament? Prospective comparative study. World journal of orthopedics. 2021;12(6):423-32.
18. Gobbi A, Karnatzikos G, Mahajan V, Malchira S. Platelet-rich plasma treatment in symptomatic patients with knee osteoarthritis: preliminary results in a group of active patients. Sports health. 2012;4(2):162-72.
19. Cole BJ, Seroyer ST, Filardo G, Bajaj S, Fortier LA. Platelet-rich plasma: where are we now and where are we going? Sports health. 2010;2(3):203-10.
20. Mishra A, Woodall J, Jr., Vieira A. Treatment of tendon and muscle using platelet-rich plasma. Clinics in sports medicine. 2009;28(1):113-25.
21. McCarrel T, Fortier L. Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression. Journal of orthopaedic research : official publication of the Orthopaedic Research Society. 2009;27(8):1033-42.
22. Seijas R, Ares O, Cusco X, Alvarez P, Steinbacher G, Cugat R. Partial anterior cruciate ligament tears treated with intraligamentary plasma rich in growth factors. World journal of orthopedics. 2014;5(3):373-8.
23. Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. The International journal of oral & maxillofacial implants. 1999;14(4):529-35.
24. Gobbi A, Bathan L, Boldrini L. Primary repair combined with bone marrow stimulation in acute anterior cruciate ligament lesions: results in a group of athletes. The American journal of sports medicine. 2009;37(3):571-8.
25. Kanaya A, Deie M, Adachi N, Nishimori M, Yanada S, Ochi M. Intra-articular injection of mesenchymal stromal cells in partially torn anterior cruciate ligaments in a rat model. Arthroscopy. 2007;23(6):610-7.
26. Centeno CJ, Pitts J, Al-Sayegh H, Freeman MD. Anterior cruciate ligament tears treated with percutaneous injection of autologous bone marrow nucleated cells: a case series. Journal of pain research. 2015;8:437-47.
27. Centeno C, Lucas M, Stemper I, Dodson E. Image guided injection of anterior cruciate ligament tears with autologous bone marrow concentrate and platelets: Midterm analysis from a randomized controlled trial. Bio Orthop J [Internet]. 2022 Jan. 2 [cited 2023 Apr. 25];3(SP2):e7-e20. Available from: https://www.biologicortho.com/index.php/BiologicOrtho/article/view/24
28 Murrell WD, Anz AW, Badsha H, Bennett WF, Boykin RE, Caplan AI. Regenerative treatments to enhance orthopedic surgical outcome. PM R. 2015 Apr;7(4 Suppl):S41-S52. doi: 10.1016/j.pmrj.2015.01.015. PMID: 25864660